Because they produce OHD at 1/10th of the retail value of other biostimulants instead of 1/10th of the production cost like they originally claimed
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive
The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint